Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wai-Ling Au"'
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 13, Iss 1 (2010)
Purpose: A draft guidance on tape stripping for assessing the bioavailability/bioequivalence of topical formulations was issued by the United States Food and Drug Administration in 1998 but has since been withdrawn. This was due to problems associate
Externí odkaz:
https://doaj.org/article/b9df5f3bb36144e3949bd507a4985ad0
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 11, Iss 1 (2008)
ABSTRACT - PURPOSE: The assessment of the degree of skin blanching following the application of a formulation containing a topical corticosteroid has been established as a surrogate method for the determination of bioequivalence of such topical prepa
Externí odkaz:
https://doaj.org/article/2e2ff8f7519445de9ec0d0edf318df4c
Autor:
Siu-Ki Chan, Wai-Ling Au, Jintao Hu, Kui-Fat Chan, Thazin Hlaing, Yun-Bi Ni, Gary Tse, Julia Y S Tsang, Sai-Yin Cheung, Kwan-Yin Lo
Publikováno v:
Breast Cancer Research and Treatment. 162:19-30
Clinical trials showing programmed death (PD)-1–PD-ligand 1 (L1) axis as a promising therapeutic target in melanoma and non-small cell lung cancers have made the pathway a focus of recent attention. However, the data regarding PD-L1/PD-1 in breast
Publikováno v:
Generic Drug Product Development ISBN: 9780429132926
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aaca41f5f517bb430a54edc361e9a35b
https://doi.org/10.3109/9781420020038-6
https://doi.org/10.3109/9781420020038-6
Publikováno v:
Skin Pharmacology and Physiology. 25:17-24
Dermal microdialysis was used to assess the bioavailability of a topical corticosteroid, clobetasol propionate, following application onto the skin of human subjects. The penetration of clobetasol propionate from a 4% m/v ethanolic solution applied o
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 13, Iss 1 (2010)
Purpose: A draft guidance on tape stripping for assessing the bioavailability/bioequivalence of topical formulations was issued by the United States Food and Drug Administration in 1998 but has since been withdrawn. This was due to problems associate